Khảo sát chất lượng cuộc sống của bệnh nhân ung thư biểu mô tuyến giáp thể nhú và thể nang sau phẫu thuật cắt tuyến giáp tại Trung tâm Ung Bướu Bệnh viện Trung ương Thái Nguyên năm 2023=Survey the quality of life of patients with papillary and follicular thyroid carrcinoma post thyroidectomy in Thai Nguyen Oncology Centre

0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Thị Thùy Linh Hoàng, Diệu Thu Lê, Thị Như Quỳnh Lê, Bảo Ngọc Trần, Bích Huyền Vũ

Ngôn ngữ: vie

Ký hiệu phân loại:

Thông tin xuất bản: Tạp chí Y học Việt Nam (Tổng hội Y học Việt Nam), 2024

Mô tả vật lý: tr.158-164

Bộ sưu tập: Metadata

ID: 243059

Thêm vào giỏ

Thyroid cancer (TC) is the most common type of cancer in the endocrine glands. Although TC is considered a "good" type of cancer, many current studies around the world have shown that surgery and combined approachs affect the patient's quality of life and survivals physically, mentally and socioeconomically. Research subjects and methods: The study was conducted on 151 patients with a confirmed diagnosis of thyroid carcinoma who underwent thyroidectomy at Thai Nguyen Oncology Center from January 2023 to October/ 2023. Patients completed the EORTC - C30 questionnaire to assess QoL at the time of follow-up examination and at treatment session I131. Objective: To survey the quality of life of patients with papillary and follicular thyroid carcinoma after thyroidectomy. Results: Research shows that the average QOL score is: 81,23 ± 14,78. (on a scale of 0 - 100, 100 points is best). Through data analysis, it has been shown that female gender factors, laryngeal nerve damage, stage of disease, number of I131 treatments session, thyroid hormone deficiency or excess have an impact on the reduction in QoL scores of patients who underwent thyroidectomy. Conclusion: mean QoL score was 81,23 ± 14,78Ung thư tuyến giáp (UTTG) là loại ung thư hay gặp nhất trong các tuyến nội tiết. Mặc dù UTTG được xem như là một loại ung thư “tốt” nhưng nhiều nghiên cứu hiện nay trên thế giới đã chỉ ra rằng phẫu thuật cùng với các phương pháp kết hợp điều trị UTTG ảnh hưởng lên CLCS của bệnh nhân trong thời gian sống thêm sau đó về cả thể chất lẫn tinh thần và kinh tế xã hội. Đối tượng và phương pháp nghiên cứu: Nghiên cứu tiến hành trên 151 bệnh nhân chẩn đoán xác định là ung thư biểu mô tuyến giáp đã được phẫu thuật cắt tuyến giáp tại Trung tâm Ung Bướu Thái Nguyên từ tháng 01/2023 đến tháng 10/2023. Bệnh nhân hoàn thành bộ câu hỏi EORTC - C30 đánh giá CLCS tại thời điểm tái khám và vào đợt điều trị I131. Mục tiêu: Khảo sát chất lượng cuộc sống của bệnh nhân ung thư biểu mô tuyến giáp thể nhú và thể nang sau phẫu thuật cắt tuyến giáp. Kết quả: Nghiên cứu cho thấy điểm CLCS trung bình là: 81,23 ± 14,78. (trên thang điểm 0 - 100, 100 điểm là tốt nhất). Qua phân tích sô liệu cho thấy các yếu tố giới nữ, tổn thương thần kinh thanh quản, giai đoạn bệnh, số lần điều trị I131, sự thiếu hụt hay dư thừa quá mức hoocmon tuyến giáp có ảnh hưởng tới sự giảm điểm CLCS của bệnh nhân sau phẫu thuật ung thư biểu mô tuyến giáp. Kết luận: Điểm chất lượng cuộc sống chung của bệnh nhân là 81,23 ± 14,78.

1. Đọc trực tuyến

1. Đọc trực tuyến

Tạo bộ sưu tập với mã QR